drugset / Trial / NCT00482209

Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation

NCT00482209

Completed 1220 enrolled Gynuity Health Projects
RandomizedParallel-groupDouble-blindTreatment

Summary

This double-blind, randomized study will compare the efficacy and acceptability of mifepristone 200mg followed in 36-48 hours by 400mcg or 800mcg of buccal misoprostol (i.e., in the cheeks) for termination of pregnancy in women up to 63 days LMP.

Timeline

Start
2007-05
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mifepristone Small molecule 200 mg
Comparator Misoprostol Other / unclassified 400 ug Other
Comparator Misoprostol Other / unclassified 800 ug Other

Indications

No indication recorded.